Search Results for: colitis

September 12, 2024September 12, 2024

Extracorporeal photophoresis in treatment of corticosteroid refractory colitis induced by combined immunotherapy for metastatic melanoma.

Melanoma Literature

Publication date: Sep 11, 2024 Concepts Keywords Colitis Acad Dermatol Colitis Immunotherapy Combined Metastatic Corticosteroid Photophoresis Dermatol Eur Extracorporeal Immunotherapy Induced Melanoma Metastatic Photophoresis Refractory Treatment Venereol Semantics Type Source ... Read more

August 28, 2024August 28, 2024

Microbiotica’s Microbiome Medicines in Melanoma and Ulcerative Colitis Gain Regulatory Approvals in EU and UK for Phase 1b Studies

Melanoma News

Publication date: Aug 28, 2024 (Study identifiers 2023-507376-50 (EudraCT)). Story continuesClaire Birrell, Microbioticas VP Clinical Development, said, The treatment of patients with advanced melanoma has been revolutionised by ICIs. By ... Read more

August 21, 2024August 21, 2024

SARS-CoV-2 as a potential trigger for microscopic colitis in a young adult: A case report.

Coronavirus Literature

Publication date: Aug 15, 2024 This case highlights the potential role of SARS-CoV-2 in triggering lymphocytic colitis, emphasizing the need for further research and vigilance in identifying potential post-COVID-19 GI ... Read more

August 16, 2024August 16, 2024

Oral aged garlic (Allium sativum) alleviates ulcerative colitis in mice by improving gut homeostasis.

Parkinson's Disease Literature

Publication date: Aug 15, 2024 Aged garlic, obtained by heating raw garlic (Allium sativum) under high temperature and controlled humidity for a period, possesses a wide range of bioactivities, but ... Read more

October 12, 2024October 12, 2024

Quality of life under treatment with the immune checkpoint inhibitors ipilimumab and nivolumab in melanoma patients. Real-world data from a prospective observational study at the Skin Cancer Center Kiel.

Melanoma Literature

Publication date: Oct 10, 2024 Combined immunotherapy (ipilimumab + nivolumab) has improved survival in stage IV melanoma patients, making Health-related Quality of Life (HrQoL) crucial due to potential immune-related adverse events (irAEs). ... Read more

October 12, 2024October 12, 2024

Quality of life under treatment with the immune checkpoint inhibitors ipilimumab and nivolumab in melanoma patients. Real-world data from a prospective observational study at the Skin Cancer Center Kiel.

Melanoma Literature

October 10, 2024October 10, 2024

Cytomegalovirus infection protects against metastatic melanoma and modulates oncological outcome and toxicity to checkpoint immunotherapy

Melanoma News

Publication date: Oct 08, 2024 The relationship between chronic viral infection and cancer response to immune checkpoint blockade (ICB) is poorly understood. Cytomegalovirus (CMV) infection is globally endemic and causes ... Read more

October 7, 2024October 7, 2024

Proprotein Convertase Subtilisin/Kexin Type 9 Induction in COVID-19 Is Poorly Associated with Disease Severity and Cholesterol Levels.

Coronavirus Literature

Publication date: Jul 17, 2024 SARS-CoV-2 infection was shown to induce proprotein convertase subtilisin/kexin type 9 (PCSK9) plasma levels in sepsis. Here, we investigate the association between serum PCSK9 levels ... Read more

October 7, 2024October 7, 2024

Proprotein Convertase Subtilisin/Kexin Type 9 Induction in COVID-19 Is Poorly Associated with Disease Severity and Cholesterol Levels.

Coronavirus Literature

October 7, 2024October 7, 2024

Proprotein Convertase Subtilisin/Kexin Type 9 Induction in COVID-19 Is Poorly Associated with Disease Severity and Cholesterol Levels.

Coronavirus Literature